Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9167 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.9128 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8926 |
High Similarity |
NPD7411 |
Suspended |
0.8921 |
High Similarity |
NPD1240 |
Approved |
0.8904 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8816 |
High Similarity |
NPD7768 |
Phase 2 |
0.8803 |
High Similarity |
NPD1510 |
Phase 2 |
0.8794 |
High Similarity |
NPD1607 |
Approved |
0.8782 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8733 |
High Similarity |
NPD4380 |
Phase 2 |
0.8681 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8681 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8621 |
High Similarity |
NPD1549 |
Phase 2 |
0.859 |
High Similarity |
NPD6959 |
Discontinued |
0.8562 |
High Similarity |
NPD7819 |
Suspended |
0.8531 |
High Similarity |
NPD6651 |
Approved |
0.8516 |
High Similarity |
NPD7075 |
Discontinued |
0.8442 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8375 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8356 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8333 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8323 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8311 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8302 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8272 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8258 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8199 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8199 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8199 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8165 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8165 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8141 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8108 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8092 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8092 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8089 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8013 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7947 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7919 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7892 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7877 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7875 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7875 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7821 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7812 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7806 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7806 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7806 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7784 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7778 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7748 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7748 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7748 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7748 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7748 |
Intermediate Similarity |
NPD5406 |
Approved |
0.774 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7738 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7738 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7727 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7722 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7712 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7707 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7692 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7682 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7682 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7665 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7662 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7651 |
Intermediate Similarity |
NPD943 |
Approved |
0.7647 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7619 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.761 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7603 |
Intermediate Similarity |
NPD2798 |
Approved |
0.76 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7595 |
Intermediate Similarity |
NPD920 |
Approved |
0.7586 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7517 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7516 |
Intermediate Similarity |
NPD6100 |
Approved |
0.75 |
Intermediate Similarity |
NPD2309 |
Approved |
0.75 |
Intermediate Similarity |
NPD8312 |
Approved |
0.75 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7485 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7468 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7442 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.74 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7381 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7379 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7379 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7343 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7338 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7325 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7324 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7318 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7318 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7301 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7297 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7296 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7273 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.726 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.726 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7255 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7255 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD919 |
Approved |
0.7244 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7243 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7243 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7222 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7219 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7219 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7212 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7191 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7189 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7189 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7189 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7182 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7182 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7178 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7168 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.712 |
Intermediate Similarity |
NPD6780 |
Approved |
0.712 |
Intermediate Similarity |
NPD6778 |
Approved |
0.712 |
Intermediate Similarity |
NPD6782 |
Approved |
0.712 |
Intermediate Similarity |
NPD6777 |
Approved |
0.712 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.712 |
Intermediate Similarity |
NPD6781 |
Approved |
0.712 |
Intermediate Similarity |
NPD6776 |
Approved |
0.712 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7115 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7105 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7097 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7079 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7074 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7067 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7067 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7066 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7052 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD37 |
Approved |
0.7048 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7037 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7032 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7022 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD1876 |
Approved |
0.6993 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6989 |
Remote Similarity |
NPD6104 |
Discontinued |
0.6988 |
Remote Similarity |
NPD5890 |
Approved |
0.6988 |
Remote Similarity |
NPD5889 |
Approved |
0.698 |
Remote Similarity |
NPD1608 |
Approved |
0.6977 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6975 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6964 |
Remote Similarity |
NPD2296 |
Approved |
0.6963 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6963 |
Remote Similarity |
NPD7874 |
Approved |
0.6952 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6948 |
Remote Similarity |
NPD1296 |
Phase 2 |
0.6941 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6939 |
Remote Similarity |
NPD1651 |
Approved |
0.6928 |
Remote Similarity |
NPD6585 |
Discontinued |
0.6928 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6927 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6927 |
Remote Similarity |
NPD7801 |
Approved |
0.6927 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD4966 |
Approved |
0.6923 |
Remote Similarity |
NPD4965 |
Approved |
0.6923
|
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |